![]() MorphoSys MorphoSys is a biotechnology company focused on the research and development of fully human antibodies. | Prometheus Biosciences Prometheus Biosciences (formerly known as Precision IBD) is a biopharmaceutical company committed to the discovery, development, and commercialization of therapeutics and diagnostics for patients with gastroenterology and autoimmune diseases. | Medicalsystem Biotechnology Medicalsystem Biotechnology (美康生物) is an integrated systems and healthcare service provider. | |
Founding Date | Founding Date 1992 | Founding Date 1995 | Founding Date 2003 |
Type | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Planegg, DE HQ Boston, US | Locations San Diego, US HQ | Locations Ningbo Shi, CN HQ |
Employees | Employees 464 | Employees 9735% increase | Employees 2,104 |
Financial | |||
Revenue (est.) | Revenue (est.) €238.3m (FY, 2023) | Revenue (est.) $6.8m (FY, 2022) | Revenue (est.) ¥1.7b (FY, 2024) |
Cost of goods | Cost of goods €34.6m (FY, 2023) | Cost of goods N/A | Cost of goods ¥966.1m (FY, 2024) |
Gross profit | Gross profit €205.5m (FY, 2023) | Gross profit N/A | Gross profit ¥761m (FY, 2024) |
Net income | Net income (€189.7m) (FY, 2023) | Net income ($141.8m) (FY, 2022) | Net income ¥262.7m (FY, 2024) |
Funding | |||
Total funding raised | Total funding raised $ 126m | Total funding raised $ 130m | Total funding raised N/A |
Prometheus Biosciences (formerly known as Precision IBD) is a biopharmaceutical company committed to the discovery, development, and commercialization of therapeutics and diagnostics for patients with gastroenterology and autoimmune diseases.
View companyMedicalsystem Biotechnology (美康生物) is an integrated systems and healthcare service provider.
View company